相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Matthew R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Lesley Uttley et al.
PHARMACOECONOMICS (2017)
Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance data
Lucie-Marie Scailteux et al.
EUROPEAN JOURNAL OF CANCER (2017)
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
Larysa H. M. Rydzewska et al.
EUROPEAN JOURNAL OF CANCER (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2017)
Testosterone suppression with a unique form of leuprorelin acetate as a solid biodegradable implant in patients with advanced prostate cancer: results from four trials and comparison with the traditional leuprorelin acetate microspheres formulation
Mladen Solaric et al.
THERAPEUTIC ADVANCES IN UROLOGY (2017)
Characteristics and external validity of the German Health Risk Institute (HRI) Database
Frank Andersohn et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries
Martin C. S. Wong et al.
EUROPEAN UROLOGY (2016)
Cardiovascular risk of androgen deprivation therapy for treatment of hormone-dependent prostate cancer. Differences between GnRH antagonists and GnRH agonists
C. Tschoepe et al.
HERZ (2016)
Androgen deprivation therapy as backbone therapy in the management of prostate cancer
Axel S. Merseburger et al.
ONCOTARGETS AND THERAPY (2016)
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
Charles J. Ryan et al.
LANCET ONCOLOGY (2015)
Cross-sectional analysis of routine treatment for prostate cancer patients. CAPRIS - a healthcare research project of the IQUO
M. Schulze et al.
UROLOGE (2014)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Experience with degarelix in the treatment of prostate cancer
Neal D. Shore
THERAPEUTIC ADVANCES IN UROLOGY (2013)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Nancy L. Keating et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
Michel Bolla et al.
LANCET ONCOLOGY (2010)
Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31
Jason A. Efstathiou et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in Europe
U. W. Tunn et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2009)
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
Christopher S. Saigal et al.
CANCER (2007)
Therapy insight: parenteral estrogen treatment for prostate cancer - a new dawn for an old therapy
Jeremy Ockrim et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Prognostic significance of obstructive uropathy in advanced prostate cancer
MG Oefelein
UROLOGY (2004)
Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer
CF Heyns et al.
BJU INTERNATIONAL (2003)
分享论文
